Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties

Chem Pharm Bull (Tokyo). 2022;70(10):679-683. doi: 10.1248/cpb.c22-00345.

Abstract

The liver X receptor is a nuclear hormone receptor that regulates lipid metabolism. Previously, we had demonstrated the antiviral properties of a liver X receptor antagonist associated with the hepatitis C virus and severe acute respiratory syndrome coronavirus 2. In this study, we screened a chemical library and identified two potential liver X receptor antagonists. Spectroscopic analysis revealed that the structures of both antagonists (compounds 1 and 2) were cyclic dimer and trimer of esters, respectively, that consisted of phthalate and 1,6-hexane diol. This study is the first to report the structure of the cyclic trimer of phthalate ester. Further experiments revealed that the compounds were impurities of solvents used for purification, although their source could not be traced. Both phthalate esters exhibited anti-hepatitis C virus activity, whereas the cyclic dimer showed anti-severe acute respiratory syndrome coronavirus 2 activity. Cyclic phthalate derivatives may constitute a novel class of liver X receptor antagonists and broad-spectrum antivirals.

Keywords: antagonist; antiviral; cyclic phthalate derivative; liver X receptor.

MeSH terms

  • Antiviral Agents / pharmacology
  • COVID-19*
  • Esters* / pharmacology
  • Hepacivirus
  • Hexanes
  • Humans
  • Liver X Receptors
  • Phthalic Acids
  • Receptors, Cytoplasmic and Nuclear
  • SARS-CoV-2
  • Solvents

Substances

  • Antiviral Agents
  • Esters
  • Hexanes
  • Liver X Receptors
  • Phthalic Acids
  • Receptors, Cytoplasmic and Nuclear
  • Solvents
  • phthalic acid